A comparative study of 131I and 177Lu labeled somatostatin analogues for therapy of neuroendocrine tumours.


This work analysed the influence of the chelating group and radioligand on somatostatin analogues in vivo and in vitro properties. The presence of DOTA in the radioiodinated peptide produced a labeled analogue with similar blood kinetics and biodistribution to (177)Lu-DOTATATE and with lower abdominal uptake than (131)I-TATE. In addition, (131)I-DOTATATE… (More)
DOI: 10.1016/j.apradiso.2008.09.009


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics